Edit, not 100 percent sure why the priority all the sudden,
Edit, not 100 percent sure why the priority all the sudden, but yes it’s been mentioned several times during CCs. I believe Kelly specifically mentioned it during a CC and also said something to the effect of strong signals in this area.
I’d have to go looking for the CC and what exactly was said but it’s definitely been on managements radar, maybe we haven’t discussed much about it much here.
MGK can probably quote some stuff from the CCs. If not I’ll look later.
“Back around August-September 2023, CytoDyn in fact was originally slated to participate in a large MD Anderson ColoRectal Cancer clinical trial in combination with Keytruda. Originally, Scott Kelly was the key individual who arranged the murine study with Keytruda and made it a reality. Cyrus Arman though, was the man responsible for taking the results of that murine study and getting the CRC clinical trial all worked out. Unfortunately, CytoDyn shut down Cyrus' plans; they shut down his baby, the CRC clinical trial at MD Anderson; (reading that highlighted post now in retrospect proves interesting). In consideration of ohm20's reasoning, which I completely do agree with, I hypothesize that the murine study at MD Anderson had determined that leronlimab did all the meaningful work. This would be of no big surprise because in addition to being a direct CCR5 blockade, leronlimao also acts as an indirect blockade of PD-1. This would seem to indicate that Keytruda wouldn't have done much at all in terms of shrinking the impossible to treat MicroSatellite Stable tumors, (the tumors which vastly outnumber the treatable MicroSatellite Unstable tumors 5:7).“
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...
Continue Reading
Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...
Continue Reading
Setting the Stage for Innovation Ah, Berlin in September—a city that’s hardly shy of showcasing avant-garde moves. And this time, we’re not talking about some cryptic art installation or underground techno rave. Nope, it's PITAKA making waves, transforming an edgy display at The Feuerle Collection. You see, on September 5, they unveiled their 'Wind Over Wheat'...
Continue Reading
A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...
Continue Reading
Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...
Continue Reading
Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...
Continue Reading
CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...
Continue Reading
Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...
Continue Reading
LG's Latest Dazzler: RGB Evo Takes the Spotlight LG has never been shy about setting standards in the home entertainment sector, and they’re doing it again at IFA 2026 with their high-purity RGB displays. Make no mistake, when LG rolls out a massive LCD TV certified by TÜV Rheinland for color purity, every other home theater manufacturer is scrambling to keep up. "LG...
Continue Reading
UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...
Continue Reading
Top 5 Most Recently Viewed Articles
Femasys Secures Substantial $8 Million Financing Femasys Inc. (NASDAQ: FEMY), an innovative leader in women's health, has recently closed an important financing round totaling $8 million. This financial boost is aimed at accelerating the commercialization of transformative fertility solutions and non-surgical permanent birth control options, expanding accessibility and...
Continue Reading
The Federal Reserve's Interest Rate Adjustments The Federal Reserve recently made headlines by reducing its benchmark interest rate by 25 basis points. This action marks the third consecutive cut and indicates a deliberate sense of caution regarding future monetary policy changes. As many anticipated, the Federal Open Market Committee (FOMC) has brought the federal funds...
Continue Reading
Mount Logan Capital Secures Enhanced Funding for Growth Strategy Incremental $13 million enhances business capabilities Amendment focuses on reducing debt costs through performance-based incentives Mount Logan Capital Inc. has taken a significant step in fortifying its financial structure by amending its existing credit agreement. The latest adjustment allows Mount...
Continue Reading
Thumzup Media Corporation Expands Its Reach in Florida Thumzup is embarking on an exciting journey to expand its operations throughout Florida, specifically targeting vibrant locales such as Miami, Fort Lauderdale, and West Palm Beach. The company is determined to harness its resources to strengthen relationships with local businesses while creating new opportunities for...
Continue Reading
IM Cannabis Completes Private Placement and Debt Settlement IM Cannabis Corp. (NASDAQ: IMCC) has completed a significant non-brokered private placement offering as part of its strategy to strengthen its financial standing. This move follows up on an earlier announcement regarding their capital-raising efforts. The company has successfully issued 742,517 Units at a price...
Continue Reading